Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Duvelisib in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma (PTCL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03372057
Recruitment Status : Active, not recruiting
First Posted : December 13, 2017
Last Update Posted : May 18, 2021
Sponsor:
Information provided by (Responsible Party):
SecuraBio

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : November 2021
Estimated Study Completion Date : December 2021